Comments on Draft Policy, “NIH Intramural Research Program: Promoting Equity Through Access Planning”

Gabriele SME, Martin MJ, Kesselheim AS - National Institutes of Health (NIH)

  • Innovation Incentives and Competition
  • Price, Value, and Access

Summary:

The commenters support finalizing NIH’s proposed policy requiring licensees of NIH-developed technologies to submit access plans, recommending the inclusion of reasonable pricing commitments in such access planning. They also urge the agency to require public disclosure of access plans, consider patent type and license exclusivity when evaluating plans, and implement systematic annual reporting to monitor licensee compliance.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access